Extended Data Fig. 3: Trust in science, health authorities, government and pharmaceutical industry. | Nature Medicine

Extended Data Fig. 3: Trust in science, health authorities, government and pharmaceutical industry.

From: Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023

Extended Data Fig. 3

Sample size for each individual country n = 1,000. Middle- Income Countries (MIC): Brazil, China, Ecuador, Ghana, India, Kenya, Mexico, Nigeria, Peru, Russia, South Africa, Turkiye. High-Income Countries (HIC): Canada, France, Germany, Italy, Poland, Singapore, South Korea, Spain, Sweden, United Kingdom, United States. Survey items: (a) ‘I trust the science behind the COVID-19 vaccines available to me,’ (b) ‘How much do you trust the health authorities that recommended you get a COVID-19 vaccine?,’ (c) ‘How much did you trust your government’s management of the COVID-19 pandemic in your country?,’ (d) ‘Did the development of COVID-19 vaccines affect your trust in science generally?,’ (e) ‘Did the development of the COVID-19 vaccines affect your trust in the pharmaceutical industry?’.

Back to article page